Close Menu

A Coherent Call

In a New York Times op-ed James Watson makes a plea for restarting the "War on Cancer" — he says that "any claim that we are still 'at war' elicits painful sarcasm." He goes on to note that new vigor for the initiative should come from the top, as the US president is the one to pick the NCI head. Watson hopes that person provides strong leadership as well as experience in developing new pharmaceuticals.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.